RxE2 is entirely revolutionizing how clinical trials are conducted by utilizing, for the first time ever, community pharmacists, powered by our cutting-edge technology that provides patient recruitment, dispensing, counseling, and operational services to the pharmaceutical and biotech industries. For more information, go to https://www.rxe2.com/.

OxSonics is a pioneering clinical-stage company on a mission to transform cancer treatment with its breakthrough SonoTran® technology, utilising Innovative proprietary sonosensitive particles, co-administered with anti-cancer drugs, and “activated” by a novel ultrasound device. This enhances the delivery of oncology drugs into solid tumours, improving efficacy and/or reducing off-target toxicity. To learn more please visit: https://oxsonics.com/

MYRA EB SYSTEMS revolutionizes clinical trials with VR solutions that enhance patient recruitment, retention, and engagement. Our VR technology supports remote monitoring, immersive training for clinical staff, and streamlined data collection and analysis, leading to more efficient, accurate trials and improved patient outcomes in drug development. For more information, go to https://myraebsystems.com/

Biora Therapeutics is a clinical-stage biotech developing two smart pill-based therapeutics platforms: the NaviCap™ platform for colon-targeted treatment of IBD, designed to improve patient outcomes through treatment at the site of disease in the gastrointestinal tract, and the BioJet™ platform for oral delivery of large molecules, designed to replace injection with needle-free, oral delivery for better management of chronic diseases. For more information, please visit https://www.bioratherapeutics.com/

Asahi Kasei Corporation (Headquarters: Tokyo, Japan) is the leading manufacturer and supplier of functional pharma excipients, such as microcrystalline cellulose, in Japan. In order to further address the rising demands in formulation research, we are now developing a cutting-edge pharma excipient primarily for injections: hyaluronic acid nanogel, Sonanos™. The Sonanos™ can act as a DDS carrier, facilitating sustained release or solubility enhancement of APIs. For more information, please visit https://www.ceolus.com/en/sonanos/hyaluronic_acid_nanogel/

To help you seize the opportunity of patient-centric drug delivery devices, we’ve built on more than 40 years’ experience designing, developing, manufacturing and commercialising drug delivery systems, from auto-injectors to inhalers to connected systems. We combine this experience with our world-class digital, AI and data development and implementation capabilities, providing you with practical, realistic and achievable recommendations, to help you unlock the full potential of drug delivery systems in the new era of connected health. For more information, please visit https://www.paconsulting.com/industries/life-sciences/pharma-and-biotech/drug-delivery

In an era of accelerating change, Exponent is the only premium engineering and scientific consulting firm with the depth and breadth of expertise to solve our clients’ most profoundly unique, unprecedented, and urgent challenges. Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world. For more information, go to: https://www.exponent.com/

MMG is a full-service patient recruitment agency that has helped clinical trial programs of all sizes accelerate their enrollment goals for almost four decades.  Through our data-driven strategies, and MMG’s “ME” program that closes the gaps in health equity and access, we are trusted leaders in trial recruitment and pride ourselves in our expertise. MMG’s “me” is a method powered by over 20 years of community-focused outreach to deliver clinical trial recruitment that overcomes critical enrollment barriers and achieves appropriate representation. MMG is a member of the world's largest healthcare communications network, Omnicom Health Group (OHG). The clinical trials we support benefit from our access to OHG's cutting-edge communication solutions and coveted partnerships in research, analytics, and digital technologies, as well as The Omnicom Group's vast buying power. For more information, go to mmgct.com. 

EmVenio Research, a PCM Trials Company, provides a scalable network of clinical trial sites strategically located in underrepresented communities to engage a diverse patient demographic. Our extensive global network comprises highly skilled clinicians, leading principal investigators, and cutting-edge research sites, allowing us to deliver high-quality clinical research services that prioritize reducing the burden on patient participation. For more information, go to https://emvenio.com/

Dandelion Health is a real world data platform that catalyzes novel research across the end-to-end drug lifecycle through multimodal data and validated clinical AI. Founded by the world's leading experts in healthcare and AI, Dandelion is a diverse and growing consortium of leading healthcare systems from across the United States. For more information, go to https://dandelionhealth.ai/

BENTO BIOLOGY PLATFORMS has created a new playbook to move the needle on clinical trial accrual, trial completion and equitable patient-finding so the drugs and therapies patients need can come to market as soon as possible. BENTO transforms clinical trial participation into an immersive user experience, capable of ensuring that participation in clinical trials is accessible and inclusive, from the comfort of of participants’ homes, with an engine for building trust in distrustful communities. Bento’s play-to-learn (P2L) and participate-to-earn (P2E) incentive platform, coupled with Bento’s marketplace of self-service biosampling tools and kitting software, distinguish it from other decentralized clinical trial (DCT) companies and legacy CROs. Well-designed digital token incentives gamify medication education, improve inclusion, mobilize enrollment, and accelerate time-to-endpoint. 100% of end users report BENTO Experience makes it easy to participate and increases participants’ desire to complete trial tasks. In 2024, Bento received the Patient Empowerment Platform of the year, as well as a prestigious “Federal 100” technology award for advancing health equity. For more information, go to https://www.bentobio.com/

Joymed Technology is a leading Contract Development and Manufacturing Organization (CDMO) in the medical device industry, dedicated to providing comprehensive research and development, clinical trial, regulatory approval, and contract manufacturing services for global medical device companies and clinical institutions.

For more information, please visit https://www.joymedtech.com/